Soluble biomarkers of cartilage and bone metabolism in early proof of concept trials in psoriatic arthritis: effects of adalimumab versus placebo
about
Changes in serum and synovial fluid biomarkers after acute injury (NCT00332254).Markers of inflammation and bone remodelling associated with improvement in clinical response measures in psoriatic arthritis patients treated with golimumab.Is psoriatic arthritis a result of abnormalities in acquired or innate immunity?Biomarkers of cartilage and surrounding joint tissue.Biomarkers in psoriatic arthritis: a systematic literature review.Clinical Features of Psoriatic Arthritis: a Comprehensive Review of Unmet Clinical Needs.Exploring the Psoriatic Arthritis Proteome in Search of Novel Biomarkers.A clinically based protein discovery strategy to identify potential biomarkers of response to anti-TNF-α treatment of psoriatic arthritis.Acute-phase serum amyloid A regulates tumor necrosis factor α and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy.The cartilage protein melanoma inhibitory activity contributes to inflammatory arthritis.
P2860
Q34614103-2B6C55F1-E29D-48E1-AAE7-8CD6EBE825CAQ36550827-FF08361F-3460-40A0-AB24-AB5FB1C17945Q38004958-E007CB63-69F8-4A61-BCDC-D1830010F617Q38239828-253B77BA-5A88-4F14-8F08-A795AC9333B0Q38715137-5ECA626A-BF2C-4164-9249-279524D051F5Q48339070-FD28E57E-B731-4A65-B94E-C75DE9319433Q49821565-BDCAFDED-1FAB-4C49-A8DD-414C8B5B7C5BQ50960278-245CA47C-1FC8-4F33-AAB5-6838A69E2814Q54339705-6F4E38D5-39FF-4599-AE75-874CE6B70A1BQ54520123-E4FECE6C-DCA7-43D9-8577-DB5C33E4BBD9
P2860
Soluble biomarkers of cartilage and bone metabolism in early proof of concept trials in psoriatic arthritis: effects of adalimumab versus placebo
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Soluble biomarkers of cartilag ...... s of adalimumab versus placebo
@ast
Soluble biomarkers of cartilag ...... s of adalimumab versus placebo
@en
Soluble biomarkers of cartilag ...... s of adalimumab versus placebo
@nl
type
label
Soluble biomarkers of cartilag ...... s of adalimumab versus placebo
@ast
Soluble biomarkers of cartilag ...... s of adalimumab versus placebo
@en
Soluble biomarkers of cartilag ...... s of adalimumab versus placebo
@nl
prefLabel
Soluble biomarkers of cartilag ...... s of adalimumab versus placebo
@ast
Soluble biomarkers of cartilag ...... s of adalimumab versus placebo
@en
Soluble biomarkers of cartilag ...... s of adalimumab versus placebo
@nl
P2093
P2860
P921
P1433
P1476
Soluble biomarkers of cartilag ...... s of adalimumab versus placebo
@en
P2093
Arno W R van Kuijk
Danielle M Gerlag
Dominique L Baeten
Jeroen DeGroot
Nico Sakkee
Paul P Tak
Rishma C Koeman
P2860
P304
P356
10.1371/JOURNAL.PONE.0012556
P407
P577
2010-09-03T00:00:00Z